The S&P/TSX Composite Index’s 2025 rebalancing has sparked renewed interest in sector rotation strategies, particularly in gold and pharmaceuticals. These shifts reflect broader macroeconomic dynamics, including inflationary pressures, global economic uncertainty, and thematic opportunities in emerging markets. For Canadian equity investors, understanding these trends is critical to positioning portfolios for resilience and growth ahead of the September 22, 2025, implementation.
Gold Sector: A Hedge Against Macroeconomic Volatility
The March 2025 rebalancing added Endeavour Silver Corp (TSX:EDR) and G Mining Ventures Corp (TSX:GMIN) to the index, signaling a strategic tilt toward gold and silver miners [1]. This move aligns with global investor behavior, as real interest rates remain near historic lows and the U.S. dollar’s weakness amplifies demand for precious metals [2]. According to a report by S&P Dow Jones Indices,…
